Part of Danone SA, Nutricia NV is a Dutch company located in Zoetermeer that manufactures dry, condensed and evaporated dairy products.

Procter & Gamble Co. engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances. The Health Care segment includes oral care products like toothbrushes, toothpaste, and personal health care such as gastrointestinal, rapid diagnostics, respiratory, and vitamins, minerals, and supplements. The Fabric and Home Care segment consists of fabric enhancers, laundry additives and detergents, and air, dish, and surface care. The Baby, Feminine and Family Care segment sells baby wipes, diapers, and pants, adult incontinence, feminine care, paper towels, tissues, and toilet paper. The company was founded by William Procter and James Gamble in 1837 and is headquartered in Cincinnati, OH.

Beijing Silian Pharmaceutical Co., Ltd. is a private company headquartered in Beijing, China. The firm produces, manufactures and sells folic acid for maternal and child health.

Beiersdorf AG is engaged in the development, manufacture, and distribution of skin and personal care products. The firm operates through the Consumer and Tesa segments. The Consumer segment concentrates on the international skin and body care markets. The Tesa segment manufactures self-adhesive products and solutions for industry, craft businesses, and consumers. It offers its products and system solutions to industry, craft businesses, and consumers. Its brands include Eucerin, La Prairie, Labello, and Hansaplast. The company was founded by Paul C. Beiesdorf in 1882 and is headquartered in Hamburg, Germany.

DSM IP Assets BV, a subsidiary of Koninklijke DSM NV, is a company headquartered in Heerlen, the Netherlands, that develops and produces nutrition, pharmacy & material science products.

Société des Produits Nestlé SA engages in the manufacture and distribution of food, pharmaceutical, medical, and cosmetic products. The company was founded on December 15, 1936 and is headquartered in Vevey, France.

Shenzhen Ausa Pharmed Co. Ltd. is a private company headquartered in China. The firm provides drug clinical trail services.

Nutri Co., Ltd. develops, manufactures, and distributes food products for disease treatment. Its products include V CRESC, V CRESC CP 10, V CRESC Jelly, V CRESC Hi-Petit Jelly, Softia, Isotonic jelly and ISOFO jelly. The company was founded in 1963 and is headquartered in Yokkaichi, Japan.

Since 1992, Christian-based Nutramax Laboratories has been developing products for people and their pets. Located in Lancaster, South Carolina, Nutramax Laboratories Veterinary Sciences, Inc. researches and develops high quality products to support animal health. Nutramax Laboratories Consumer Care, Inc., located in Edgewood, Maryland, focuses on researching and developing products to promote consumer health. Nutramax Manufacturing, Inc. manufactures products in both the South Carolina and Maryland locations. The Nutramax Family of Companies has become industry leaders in setting and adhering to high standards in manufacturing and quality control. We continually conduct and support laboratory research and clinical studies on our products. Many of these studies have been published and/or presented in medical, veterinary and other health-related journals and publications. We believe our real strength and prosperity comes from The Lord. He has blessed our company and the talented group of employees who work together as a team.

Shenzhen Osa Pharmaceutical Co., Ltd., established on 2008-05-14, Business scope includes general business items:biomedical technology,Biotechnology,Research and development of traditional Chinese medicine technology;Information consultation on the above business;Start a business(Specific projects will be reported separately);Operating import and export business.(above laws,Administrative regulations,Except for items that are subject to approval prior to registration by decision of the State Council,Restricted projects must obtain a license before operating),The licensing program is:tablet production;Class III:6840In vitro diagnostic reagents,Class II:6840Production of clinical laboratory analysis instruments.

Jianchangbang Pharmaceutical Co., Ltd., established on 1992-06-07, Business scope includes licensed projects:pharmaceutical production,Drug Wholesale,Drug import and export,Pharmaceutical commissioned production,Drug retail,Drug internet information service,food business(Selling prepackaged food),Food Internet Sales(Selling prepackaged food),food business(sell bulk food),Health food production,Health food sales,Infant formula production,Sales of infant formula milk powder,Production of formula food for special medical purpose,Sales of formula food for special medical purposes,Food Internet Sales,beverage production,Production of tea products,Production of hygiene products and single-use medical products,Class III medical device business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) General project:Sales of hygiene products and single-use medical products,Domestic trade agent,Chinese herbal medicine planting,real estate herbal medicine(Does not contain Chinese herbal medicine)buy and sell,Sales of agricultural and sideline products,internet sales(Except for products that require a license for sale),Daily necessities sales,Sales of daily chemical products,Cosmetics Wholesale,Information Technology Consulting Services,Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion,Medical Research and Experimental Development,Standardized service,electronics sales,Office Supplies Sales,Arts and crafts and collectibles retail(Except for ivory and its products),Maternal and baby products sales,Information Consulting Service(Not including licensing information consulting services),Sales of Class II Medical Devices(Except for licensed business,Can independently operate projects that are not prohibited or restricted by laws and regulations)

Zinpro pioneered the research and development of Performance Minerals. As a family-owned, privately-held company, Zinpro's steady growth has come as a result of quality products, quality people and a focus on one thing: performance trace minerals for exceptional animal nutrition. Today, the company has regional sales offices located in 11 countries and markets its products in more than 70 countries worldwide.

Ferrer Internacional SA engages in the development, manufacture and commercialization of pharmaceutical products for the diagnosis and treatment of cardiovascular, dermatological, gastrointestinal and respiratory conditions. It also designs and produces active ingredients and nutraceuticals for the food, cosmetics and animal feed industries. The company was founded on April 17, 1940 and is headquartered in Barcelona, Spain.

Beijing Osa Pharmaceutical Research Center Co., Ltd., established on 2007-07-13, Business scope includes pharmaceutical research;traditional Chinese medicine,chemical medicine,Diagnostic reagents,Biological product technology development,technology transfer,technical consulting(Except intermediary),Technical Services;Organize cultural and artistic exchange activities(Except for performances);Sales of Class I Medical Devices;health management,Health Advisory(Except for medical treatment activities subject to approval);sell food.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Sale of food and items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Ajinomoto Co. is a global manufacturer of high-quality seasonings, processed foods, beverages, amino acids, pharmaceuticals and specialty chemicals. For many decades Ajinomoto Co. has contributed to food culture and human health through wide-ranging application of amino acid technologies. Today, the company is becoming increasingly involved with solutions for improved food resources, human health and global sustainability. Founded in 1909 and now operating in 26 countries, Ajinomoto Co. had net sales of JPY 1,197.3 billion (USD 15.1 billion) in fiscal 2011. The Ajinomoto Group Standards of Business Conduct (hereinafter the "Standards of Conduct") describe the conduct that every member of the Ajinomoto Group must understand and practice every day in order to implement the Ajinomoto Group Philosophy in accordance with the Ajinomoto Group Way. The Standards of Conduct also represent the commitments made to all stakeholders by Ajinomoto Group companies. Ajinomoto aim to be "a group of companies that contributes to human health globally" by continually creating unique value to benefit customers. To become a global group of food companies centered on the world's No. 1 seasoning business. To become a global group of aminoscience companies that contributes to humankind with the world's No. 1 amino acid technology. To become a group of health-promoting companies with a scientific approach to good taste and health.

Exeltis aim is to become a point of reference in the pharmaceutical sector.A step forward in improving healthExeltis is the result of the natural evolution and sustained growth of the CHEMO pharmaceutical business, an integrated health sciences group.

Eli Lilly engages in the discovery, development, manufacture, and sale of products in the pharmaceutical products business segment. The company manufactures and distributes products through owned or leased facilities in the United States, Puerto Rico, and 25 other countries. Its products are sold in approximately 135 countries. It also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.

Endocyte, Inc., a biopharmaceutical company, develops receptor-targeted therapeutics to treat cancer and autoimmune/inflammatory diseases. The company provides EC17, a folate-targeted hapten therapy drug to treat metastatic renal and ovarian cancer; EC145, a folate-targeted chemotherapeutic conjugate to treat various tumors, including cancers of the breast, lung, and blood; EC0225, a targeted chemotherapy drug; BMS753493, a folate-targeted anti-cancer therapy drug; EC0434 to target folate receptor positive tumors; and EC0305, an anti-cancer therapy drug. It also offers EC0286, a folate-targeted small molecule for the treatment of inflammatory diseases; and EC20, a folate-targeted radiopharmaceutical imaging agent to identify folate-receptor positive cancers. The company was founded in 1996 and is based in West Lafayette, Indiana.